illustrated that intratracheal administration of SRT1720 significantly attenuated LPS-induced acute lung injury (ALI) and lung hyper-permeability, whereas intratracheal administration of the selective SIRT1 inhibitor EX527 aggravated LPS-induced ALI (168). The gene discussed is SIRT1; the disease is acute respiratory distress syndrome.